✦ LIBER ✦

Development and characterization of novel erythropoiesis stimulating protein (NESP)

✍ Scribed by Egrie, J C; Browne, J K

Book ID: 120619464
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 366 KB
Volume: 84
Category: Article
ISSN: 0007-0920
DOI: 10.1054/bjoc.2001.1746

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and characterization of nove

Development and characterization of novel erythropoiesis stimulating protein (NESP)

✍ Egrie, J. C.; Browne, J. K. 📂 Article 📅 2001 🏛 Oxford University Press 🌐 English ⚖ 183 KB

An overview of the efficacy and safety o

An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)

✍ Macdougall, I. C. 📂 Article 📅 2001 🏛 Oxford University Press 🌐 English ⚖ 154 KB

Novel erythropoiesis stimulating protein

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

✍ Smith, R E; Jaiyesimi, I A; Meza, L A; Tchekmedyian, N S; Chan, D; Griffith, H; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 436 KB

A dose-finding and safety study of novel

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

✍ Glaspy, J; Jadeja, J Singh; Justice, G; Kessler, J; Richards, D; Schwartzberg, L 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB

Capillary electrophoresis and matrix-ass

Capillary electrophoresis and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry for analysis of the novel erythropoiesis-stimulating protein (NESP)

✍ Victoria Sanz-Nebot; Fernando Benavente; Estela Giménez; José Barbosa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract NESP (novel erythropoiesis‐stimulating protein) is a recently approved hyperglycosylated analogue of human erythropoietin (EPO) with a long‐lasting effect. In this work, the capillary electrophoresis (CE) methodology proposed by the European Pharmacopoeia for the separation of EPO glyco

A phase III, double-blind, placebo-contr

A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer

✍ R. Pirker; J. Vansteenkiste; J. Gateley; P. Yates; A. Colowick; J. Musil 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 349 KB